The Thrombopoietin Mimetics Eltrombopag and Romiplostim in the Treatment of Refractory Aplastic Anaemia

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14024
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

Eltrombopag for the Treatment of Aplastic Anemia: Current Perspectives

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Aplastic Anaemia

Bone Marrow Transplantation
TransplantationHematology
2000English

Aplastic Anaemia

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1979English

Eltrombopag: An Update on the Novel, Non-Peptide Thrombopoietin Receptor Agonist for the Treatment of Immune Thrombocytopenia

Annals of Hematology
MedicineHematology
2010English

Treatment of Aplastic Anaemia in Elderly Patients Aged >60 Years

Bone Marrow Transplantation
TransplantationHematology
2012English

Eltrombopag, a Thrombopoietin- Receptor Agonist in the Treatment of Adult Chronic Immune Thrombocytopenia: A Review of the Efficacy and Safety Profile

Therapeutic Advances in Hematology
Hematology
2012English

Retinopathy in Severe Aplastic Anaemia

BMJ Case Reports
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy